BTIG Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $5
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $9 to $5.
BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $9 to $5.